ZVSA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Zyversa Therapeutics Inc (ZVSA).


$2.48M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

ZVSA Market Cap. (MRY)


ZVSA Shares Outstanding (MRY)


ZVSA Assets (MRY)


Total Assets

$20.60M

Total Liabilities

$12.08M

Total Investments

$0

ZVSA Income (MRY)


Revenue

$0

Net Income

-$9.41M

Operating Expense

$9.14M

ZVSA Cash Flow (MRY)


CF Operations

-$7.56M

CF Investing

$0

CF Financing

$5.95M

ZVSA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

ZVSA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$20,599,414 (-6.85%)

$22,114,284

-

$1,126,174 (64.27%)

Assets Current

$1,715,797 (-48.83%)

$3,353,133

-

$811,782 (139.39%)

Assets Non-Current

$18,883,617 (0.65%)

$18,761,151

-

$314,392 (-9.26%)

Goodwill & Intangible Assets

$0 (0%)

$0

-

$0 (0%)

Shareholders Equity

$8,516,447 (-23.10%)

$11,074,598

-

-$12,831,466 (-44.35%)

Property Plant & Equipment Net

$0 (0%)

$14,772

-

$27,733 (-27.27%)

Cash & Equivalents

$1,530,924 (-51.21%)

$3,137,674

-

$328,581 (88.12%)

Accumulated Other Comprehensive Income

$0 (0%)

$0

-

$0 (0%)

Deferred Revenue

$0 (0%)

$0

-

$0 (0%)

Total Investments

$0 (0%)

$0

-

$0 (0%)

Investments Current

$0 (0%)

$0

-

$0 (0%)

Investments Non-Current

$0 (0%)

$0

-

$0 (0%)

Inventory

$0 (0%)

$0

-

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0

-

$0 (0%)

Trade & Non-Trade Payables

$9,337,267 (10.74%)

$8,431,583

-

$2,000,100 (-13.49%)

Accumulated Retained Earnings (Deficit)

-$112,632,559 (-9.12%)

-$103,219,124

-

-$52,896,817 (-18.04%)

Tax Assets

$0 (0%)

$0

-

$0 (0%)

Tax Liabilities

$851,659 (0.80%)

$844,914

-

$0 (0%)

Total Debt

$0 (0%)

$8,656

-

$9,151,508 (139.75%)

Debt Current

$0 (0%)

$8,656

-

$9,151,508 (329.63%)

Debt Non-Current

$0 (0%)

$0

-

$0 (0%)

Total Liabilities

$12,082,967 (9.45%)

$11,039,686

-

$13,626,309 (47.42%)

Liabilities Current

$11,231,308 (10.17%)

$10,194,772

-

$13,626,309 (80.33%)

Liabilities Non-Current

$851,659 (0.80%)

$844,914

-

$0 (0%)

ZVSA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$7,357,559 (-34.38%)

$11,213,201 (47.44%)

$7,605,205 (36.29%)

$5,580,099 (4.03%)

Research & Development Expense

$1,779,275 (-44.53%)

$3,207,573 (-40.69%)

$5,407,859 (154.57%)

$2,124,277 (-67.16%)

Operating Expenses

$9,136,834 (-91.52%)

$107,754,233 (728.05%)

$13,013,064 (68.90%)

$7,704,376 (-34.89%)

Interest Expense

$269,856 (59149.45%)

-$457 (-100.11%)

$427,542 (-47.95%)

$821,366 (59.04%)

Income Tax Expense

$6,745 (100.07%)

-$9,455,830 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$9,413,435 (90.42%)

-$98,297,946 (-599.75%)

-$14,047,607 (-73.77%)

-$8,084,161 (36.26%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$9,413,435 (90.42%)

-$98,297,946 (-599.75%)

-$14,047,607 (-73.77%)

-$8,084,161 (36.26%)

Preferred Dividends Income Statement Impact

$0 (0%)

$7,948,209 (-20.64%)

$10,015,837 (0%)

$0 (0%)

Net Income Common Stock

-$9,413,435 (91.14%)

-$106,246,155 (-341.53%)

-$24,063,444 (-197.66%)

-$8,084,161 (36.26%)

Weighted Average Shares

$1,110,033 (13.85%)

$975,035 (41.05%)

$691,265 (-97.14%)

$24,167,257 (2.25%)

Weighted Average Shares Diluted

$1,110,033 (13.85%)

$975,035 (41.05%)

$691,265 (-97.14%)

$24,167,257 (2.25%)

Earning Before Interest & Taxes (EBIT)

-$9,136,834 (91.52%)

-$107,754,233 (-691.14%)

-$13,620,065 (-87.53%)

-$7,262,795 (40.31%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$9,136,834 (91.52%)

-$107,754,233 (-728.05%)

-$13,013,064 (-68.90%)

-$7,704,376 (34.89%)

ZVSA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$5,952,947 (-0.06%)

$5,956,294 (219.31%)

$1,865,384 (-64.33%)

$5,230,000 (14.69%)

Net Cash Flow from Operations

-$7,559,697 (13.31%)

-$8,720,819 (-483.47%)

-$1,494,641 (70.56%)

-$5,076,089 (0.66%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,606,750 (41.88%)

-$2,764,525 (-845.67%)

$370,743 (140.88%)

$153,911 (128.00%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$5,230,000 (238.57%)

Issuance (Purchase) of Equity Shares

$766,359 (-95.12%)

$15,689,930 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$705,567 (-40.86%)

$1,192,963 (-66.16%)

$3,524,801 (-14.90%)

$4,141,736 (12.63%)

Depreciation Amortization & Accretion

$6,933 (-33.34%)

$10,400 (5.39%)

$9,868 (-5.12%)

$10,400 (0.00%)

ZVSA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-106.40% (62.97%)

-287.30%

-

74.40%

Return on Average Assets (ROAA)

-46.40% (77.96%)

-210.50%

-

-892.40%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-104.50% (65.33%)

-301.40%

-

210.40%

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.13 (-1462.50%)

-0.01 (99.96%)

-22.73 (25.15%)

-30.36

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.29 (-25.32%)

0.39

-

-7.57

Debt to Equity Ratio (D/E)

1.42 (42.33%)

1

-

-1.06 (-2.12%)

Earnings Per Share (EPS)

-8.48 (92.22%)

-108.97 (-214.49%)

-34.65 (-10400.00%)

-0.33 (38.89%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-6.81 (23.86%)

-8.94 (-313.69%)

-2.16 (-929.52%)

-0.21 (2.78%)

Book Value Per Share (BVPS)

7.67 (-32.45%)

11.36

-

-0.53 (-41.22%)

Tangible Assets Book Value Per Share (TABVPS)

18.56 (-18.18%)

22.68

-

0.05 (62.07%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-19 (-46.15%)

-13

Enterprise Value Over EBITDA (EV/EBITDA)

-0.26 (-896.15%)

-0.03 (99.86%)

-18.73 (-39.83%)

-13.4

Asset Turnover

0 (0%)

0

-

0

Current Ratio

0.15 (-53.50%)

0.33

-

0.06 (33.33%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,559,697 (13.31%)

-$8,720,819 (-483.47%)

-$1,494,641 (70.56%)

-$5,076,089 (0.66%)

Enterprise Value (EV)

$2,361,921 (-15.31%)

$2,788,880 (-98.91%)

$254,941,482 (162.41%)

$97,152,434

Earnings Before Tax (EBT)

-$9,406,690 (91.27%)

-$107,753,776 (-667.06%)

-$14,047,607 (-73.77%)

-$8,084,161 (36.26%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$9,129,901 (91.53%)

-$107,743,833 (-691.64%)

-$13,610,197 (-87.66%)

-$7,252,395 (40.34%)

Invested Capital

$7,837,182 (-10.84%)

$8,790,494

-

-$3,677,208 (-13.91%)

Working Capital

-$9,515,511 (-39.08%)

-$6,841,639

-

-$12,814,527 (-77.56%)

Tangible Asset Value

$20,599,414 (-6.85%)

$22,114,284

-

$1,126,174 (64.27%)

Market Capitalization

$2,484,842 (-42.66%)

$4,333,252 (-98.24%)

$246,082,320 (153.38%)

$97,119,852

Average Equity

$8,846,734 (-76.08%)

$36,984,566

-

-$10,860,254

Average Assets

$20,285,902 (-59.81%)

$50,476,947

-

$905,870

Invested Capital Average

$8,746,461 (-75.54%)

$35,752,876

-

-$3,452,685

Shares

2,344,191 (-51.31%)

4,814,725 (1440.79%)

312,485 (-96.78%)

9,692,600